Skip to content
Clinical Trials – home

Kinderarztpraxis Dr Kaiser - Dr. Marinesse

Verified siteinfo

Germany Tangstedter Landstr. 77, 22415 Hamburg, Germany

  • Meningococcal immunisation · Meningococcal infection · Respiratory syncytial virus infection
  • Children and adolescents

About Specializations

Kinderarztpraxis Dr Kaiser - Dr. Marinesse in Hamburg, Germany specialises in clinical trials of conditions such as Meningococcal immunisation, Meningococcal infection, Respiratory syncytial virus infection, and other specialisations. This site conducts important research.

Main research areas of the site

Bacterial Infections and Mycoses

Kinderarztpraxis Dr Kaiser - Dr. Marinesse is conducting pediatric research focused on meningococcal infection, with studies designed to assess whether MenACYW conjugate vaccine can generate a strong and lasting immune response in young children. The work centers on immunogenicity and safety, helping determine how well vaccination strategies protect infants, toddlers, children, and adolescents against serious bacterial disease.

  • Evaluating immune response to meningococcal ACYW vaccination in healthy infants and toddlers
  • Studying booster vaccination to support long-term protection against meningococcal serogroups A, C, W, and Y
  • Assessing antibody persistence and vaccine response over time in children and adolescents

These trials are helping clarify how well vaccines maintain protection across early childhood and beyond, with a practical focus on preventing invasive bacterial illness.

Virus Diseases

The site is also involved in research on viral respiratory disease, especially RSV in infants and toddlers. These studies aim to evaluate whether a vaccine can reduce the risk of serious lower respiratory tract illness while also measuring the body’s immune response and overall tolerability.

  • Testing a vaccine approach for prevention of RSV lower respiratory tract disease
  • Measuring immunogenicity and safety in young children
  • Supporting efforts to improve protection against common childhood virus diseases

This line of research reflects a broader effort to strengthen early-life defense against respiratory infections, an important area of pediatric care in Hamburg and across Europe.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Tangstedter Landstr. 7722415 HamburgGermany
Recruiting now
no trials
Conditions studied
3
Partner status
Verified site

More sites in HamburgGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Study on the Effectiveness and Safety of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Toddlers

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:534
  • Sponsor:Sanofi Pasteur Inc.

Study on the Safety and Immune Response of a Booster Dose of MenACYW Conjugate Vaccine in Children and Adolescents Previously Vaccinated for Meningococcal Infection

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:Tetanus toxoid
  • Sponsor:Sanofi Winthrop Industrie

Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Sanofi Pasteur
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.